Fundraising FoxBlade Therapeutics
South San Francisco, US · Founded 2015 · Delaware corporation · 7 known investors
Find your way into Blade Therapeutics
Each arrow is one introduction. Sign up to fill in the first one.
Ask Jill Carroll to introduce you to Wendye Robbins
You →Jill · together at Limerick Biopharma →Wendye
Sign up to find every way you can get introduced to Blade Therapeutics
- Your email: who you already know at Blade Therapeutics, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Blade Therapeutics team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Founders & leadership
Board
Investors · 7
How we know: OUP (Osage University Partners)'s portfolio page · Not right? Tell us
How we know: Pfizer Venture Investments's portfolio page · funding news · Not right? Tell us
How we know: board seat on SEC Form D · Not right? Tell us
How we know: funding news · Not right? Tell us
How we know: board seat on SEC Form D · funding news · Not right? Tell us
How we know: funding news · Not right? Tell us
Funding
SEC filings, press & company announcements$77M disclosed across 3 of 4 rounds · 2016–2019
- Undisclosed amountSeries BOct 2017Source ↗
▶$12MraisedOct 2019 · 21 investors · BiotechnologyRule 506(b)
- Prabha IbrahimExecutive Officer
- William V. SlatteryDirector
- James ScopaDirector
- Gary PatouExecutive Officer
- Lloyd B. KlicksteinDirector
- Cameron WheelerDirector
- Peter Van VlasselaerDirector
- Luke EvninDirector
- Wendye Rae RobbinsExecutive Officer, Director
- Rana Al-HallaqDirector
- M. Shirley ChiangExecutive Officer
- Offering amount
- $24M
- Amount sold
- $12M
- First sale
- Sep 2019
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$38MraisedOct 2019 · 10 investors · BiotechnologyRule 506(b)
- Rana Al-HallaqDirector
- Wendye Rae RobbinsExecutive Officer, Director
- William V. SlatteryDirector
- James ScopaDirector
- Gary PatouExecutive Officer
- Lloyd B. KlicksteinDirector
- Prabha IbrahimExecutive Officer
- M. Shirley ChiangExecutive Officer
- Cameron WheelerDirector
- Peter Van VlasselaerDirector
- Luke EvninDirector
- Offering amount
- $50M
- Amount sold
- $38M
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
▶$27.1MraisedJun 2016 · 10 investors · BiotechnologyRule 506(b)
- Luke EvninDirector
- Cameron WheelerDirector
- Peter van VlasselaerDirector
- Elaine JonesDirector
- Wendye RobbinsExecutive Officer, Director
- William SlatteryDirector
- James ScopaDirector
- Offering amount
- $45.4M
- Amount sold
- $27.1M
- First sale
- Jun 2016
- Incorporated
- Corporation, Delaware, 2015
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Founder mafia
2 people who came through Blade Therapeutics went on to found or lead other companies.
Frequently asked questions
- Who are Blade Therapeutics's investors?
- Blade Therapeutics's investors include Bay City Capital, OUP (Osage University Partners), Pfizer Venture Investments, +ND Capital, Deerfield Management Company, MPM BioImpact, Osage University Partners.
- How much funding has Blade Therapeutics raised?
- Blade Therapeutics has disclosed $77M raised across 3 of its 4 known rounds.
- Where is Blade Therapeutics headquartered?
- Blade Therapeutics is headquartered in South San Francisco, US.